EP0621893A4 - Vaccins contre le virus de la leucemie des felins. - Google Patents

Vaccins contre le virus de la leucemie des felins.

Info

Publication number
EP0621893A4
EP0621893A4 EP93903066A EP93903066A EP0621893A4 EP 0621893 A4 EP0621893 A4 EP 0621893A4 EP 93903066 A EP93903066 A EP 93903066A EP 93903066 A EP93903066 A EP 93903066A EP 0621893 A4 EP0621893 A4 EP 0621893A4
Authority
EP
European Patent Office
Prior art keywords
leukemia virus
virus vaccines
feline leukemia
feline
vaccines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP93903066A
Other languages
German (de)
English (en)
Other versions
EP0621893A1 (fr
Inventor
Keith Haffer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of EP0621893A1 publication Critical patent/EP0621893A1/fr
Publication of EP0621893A4 publication Critical patent/EP0621893A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/21Retroviridae, e.g. equine infectious anemia virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/545Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/13011Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/13011Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13034Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
EP93903066A 1992-01-06 1993-01-06 Vaccins contre le virus de la leucemie des felins. Withdrawn EP0621893A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US81745092A 1992-01-06 1992-01-06
US817450 1992-01-06
PCT/US1993/000221 WO1993014190A1 (fr) 1992-01-06 1993-01-06 Vaccins contre le virus de la leucemie des felins

Publications (2)

Publication Number Publication Date
EP0621893A1 EP0621893A1 (fr) 1994-11-02
EP0621893A4 true EP0621893A4 (fr) 1995-07-12

Family

ID=25223112

Family Applications (1)

Application Number Title Priority Date Filing Date
EP93903066A Withdrawn EP0621893A4 (fr) 1992-01-06 1993-01-06 Vaccins contre le virus de la leucemie des felins.

Country Status (5)

Country Link
EP (1) EP0621893A4 (fr)
JP (1) JPH07502897A (fr)
AU (1) AU3441693A (fr)
CA (1) CA2127466A1 (fr)
WO (1) WO1993014190A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX368220B (es) * 2008-06-27 2019-09-24 Zoetis Services Llc Composiciones adyuvantes novedosas.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4086134A (en) * 1973-09-18 1978-04-25 University Of Glasgow Method for preparation of vaccine against feline leukemia
US4034081A (en) * 1973-09-18 1977-07-05 University Of Glasgow Vaccines against feline leukemia
US4406885A (en) * 1978-12-28 1983-09-27 Research Corporation Preparation of native oncornavirus envelope subunits and vaccines therefrom
US4434157A (en) * 1979-12-18 1984-02-28 The Ohio State University Research Foundation Method of recovering cell antigen and preparation of feline leukemia vaccine therefrom
US4332793A (en) * 1979-12-18 1982-06-01 The Ohio State University Research Foundation Method of recovering cell antigen and preparation of feline leukemia vaccine therefrom
US4711778A (en) * 1980-07-30 1987-12-08 Norden Laboratories, Inc. Inactivated rabies vaccine for veterinary use
US4789702A (en) * 1984-05-18 1988-12-06 Cetus Corporation Feline leukemia virus vaccine
US4699785A (en) * 1984-09-18 1987-10-13 The Regents Of The University Of California Cell line producing feline leukemia virus
US4657761A (en) * 1985-06-05 1987-04-14 Pinto Cesar M Polyvalent non-specific immuno-stimulating vaccine and method

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
No further relevant documents disclosed *

Also Published As

Publication number Publication date
AU3441693A (en) 1993-08-03
CA2127466A1 (fr) 1993-07-22
WO1993014190A1 (fr) 1993-07-22
EP0621893A1 (fr) 1994-11-02
JPH07502897A (ja) 1995-03-30

Similar Documents

Publication Publication Date Title
GR3025363T3 (en) Medicaments.
EP0597463A3 (en) Thermotherapiesonde.
AR244558A1 (es) Un inhalador
EP0580285A3 (fr) Auto-réenclencheurs.
ZA92908B (en) Compounds.
EP0605802A3 (fr) Perforateur.
ZA927562B (en) Medicament.
AU3678184A (en) Feline leukemia virus vaccine
ZA928664B (en) Air separation.
EP0633771A4 (en) Compounds.
ZA926482B (en) Cyanophenylpyrroles.
EP0572808A3 (fr) Système de régulation antiblocage.
GB9210337D0 (en) Feline leukaemia virus vaccine
ZA927792B (en) Anti-alpha6-integrin-antibodies.
EP0668864A4 (fr) Biphenylmethylimidazopyridines substituees.
GR3024994T3 (en) Lymphoid cd30-antigen.
ZA929294B (en) Syringe.
ZA937127B (en) Catch.
ZA929590B (en) Diphenylsulphides.
ZA928508B (en) Air separation.
GB2238021B (en) Printer.
EP0599191A3 (fr) Circuit de régulation de vitesse d'un moteur.
DE69203865D1 (en) Thermo-transferdrucksystem.
ZA925725B (en) Qinolin-2-yl-methoxybenzylhydroxyureas.
EP0663819A4 (fr) Association d'ibuprofene et de cafeine.

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19940727

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched
AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 19990210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20010801